PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study

F De Benedetti; N Ruperto; HI Brunner; A Grom; N Wulffraat; M Henrickson; R Jerath; Y Kimura; AK Kadva; J Wang; A Martini; D Lovell; PRINTO; PRCSG

首页> 外文期刊>Pediatric rheumatology online journal >PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study

【24h】

PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study

机译：PReS-FINAL-2139：在非活动性疾病的全身性JIA患者中，tocilizumab的减量和停药：招标研究中另一种给药方案的结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric rheumatology online journal》 |2013年第s2期|共页
作者
F De Benedetti; N Ruperto; HI Brunner; A Grom; N Wulffraat; M Henrickson; R Jerath; Y Kimura; AK Kadva; J Wang; A Martini; D Lovell; PRINTO; PRCSG;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类小儿内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Tapering and withdrawal of tocilizumab in patients with systemic juvenile idiopathic arthritis in inactive disease: results from an alternative dosing regimen in the TENDER study [J] . F De Benedetti, N Ruperto, H Brunner, Pediatric rheumatology online journal . 2014,第S1期

机译：在无活性疾病中系统性少年特发性关节炎患者逐渐减少和撤离：招标研究中替代给药方案的结果
2. Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA [J] . Klotsche Jens, Minden Kirsten, Niewerth Martina, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2018,第7期

机译：在MTX提取之前在非活性疾病中花费的时间与贾氏患者的爆发风险有关
3. Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up [J] . Yen-Nung Liao, Ching-Shen Liu, Tong-Rong Tsai, Kaohsiung Journal of Medical Sciences . 2011,第7期

机译：系统性红斑狼疮患者中药配方逐渐减少类固醇剂量并预防疾病发作的初步研究
4. HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS (AL): AN ABMTR STUDY [C] . DH Vesole, W Perez, D Reece, International Symposium on Amyloidosis . 2005

机译：具有自体造血干细胞移植（HSCT）的高剂量治疗用于初级全身淀粉样蛋白症（AL）的患者：ABMTR研究
5. PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study [O] . F De Benedetti, N Ruperto, HI Brunner, 2013

机译：PReS-FINAL-2139：在非活动性疾病的全身性JIA患者中tocilizumab的减量和停药：招标研究中另一种给药方案的结果
6. PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study [O] . F De Benedetti, N Ruperto, HI Brunner, 2013

机译：PReS-FINAL-2139：在非活动性疾病的全身性JIA患者中，tocilizumab的减量和停药：招标研究中另一种给药方案的结果

PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study

著录项

相似文献

相关主题

期刊订阅